COMMUNIQUÉS West-GlobeNewswire

Canada is Failing Millions Living With Arthritis - But a Bold Plan Aims to End the Disease
08/04/2026
Arthritis Action Now unites 21 organizations, more than 100,000 patients, researchers, clinicians and advocates to transform arthritis research and care in Canada TORONTO, April 08, 2026 (GLOBE NEWSWIRE) -- Canada is [...]
Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
08/04/2026
SAN DIEGO, April 08, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients [...]
Catheter Precision to Attend the Annual European Heart Rhythm Association Conference
08/04/2026
FORT MILL, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that it will be attending the annual European Heart Rhythm Association (EHRA) [...]
New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia
08/04/2026
- Unprecedented improvements in arm span observed with TransCon CNP and TransCon hGH combination therapy, a measure highly meaningful to the achondroplasia community - Enhanced improvements in spinal canal dimensions [...]
Ondo Global Markets Tokenizes Enlivex’s Ordinary Shares
08/04/2026
Nes-Ziona, Israel, April 08, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced that Ondo Finance (“ [...]
RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
08/04/2026
Patent Expands Protection for the Company’s RenovoCath Device, the Novel Dual-Occlusion Catheter-Based System RenovoRx Currently Holds a Strong and Growing Global Intellectual Property Portfolio with 19 Issued or [...]
GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions
08/04/2026
Issued claims further strengthen global intellectual property portfolio supporting immune cell modulation platform and expand strategic presence in a high-growth international market LA JOLLA, CA, April 08, 2026 (GLOBE [...]
Spectral AI Names David McGuire, CPA, as Chief Financial Officer
08/04/2026
DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate [...]
Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference
08/04/2026
WAYNE, Pa., April 08, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists
08/04/2026
LA JOLLA, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new [...]
Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop
08/04/2026
Partnership Signals Commercial Readiness and Manufacturing Strength for Groundbreaking Ophthalmic Treatment COLUMBIA, S.C., April 08, 2026 (GLOBE NEWSWIRE) -- The Ritedose Corporation, Inc. (Ritedose), the largest [...]
Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026
08/04/2026
THE WOODLANDS, TX, April 08, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference
08/04/2026
Virtual presentation scheduled for Thursday, April 16th at 2:15 PM ET Access the webcast here Denver, CO, April 08, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical- [...]
Medline to report first quarter 2026 results on May 6, 2026
08/04/2026
NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026. A press release and [...]
Precision Neuroscience™ Appoints Craig Mermel as Chief AI and Data Officer
08/04/2026
As brain–computer interfaces advance, neural data emerges as a key asset. NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leading brain–computer interface (BCI) company, [...]
SafeSpace Global Corporation to Present at the Centri Capital Conference at Nasdaq MarketSite
08/04/2026
Company executives to meet with institutional and growth-focused investors at premier invite-only, one-day event in New York City KNOXVILLE, TN., April 08, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (" [...]
Aeroflow Health Celebrates Wisconsin’s Extension of Postpartum Care
08/04/2026
Aeroflow celebrates the passage of SB 23, a Wisconsin bill helping ensure new mothers have continued access to care one year after childbirth ASHEVILLE, N.C., April 08, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health , a [...]
Privia Health to Report First Quarter 2026 Results on Thursday, May 7
08/04/2026
ARLINGTON, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its first quarter ended March 31, 2026 before market open on [...]
MAIA Biotechnology Expects Recent $33 Million Capital Raise to Fully Fund Ongoing Pivotal Phase 3 Trial of Novel Telomere-Targeting Anticancer Therapy
08/04/2026
Strong participation in recent $33 million common stock offering highlights investor confidence in late-stage clinical momentum and commercial potential Statistical assessments point to high probability of technical [...]

Pages